Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pain 4Pain, Postoperative 3Agnosia 3Ovarian Neoplasms 2Inflammation 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Thyroid Nodule 1Reperfusion Injury 1Rectal Neoplasms 1Prostatic Neoplasms 1Obesity 1Neoplasms 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1Ileus 1Goiter 1End Stage Liver Disease 1Emergencies 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Curative Breast Cancer Surgery 1Constipation 1

Interventions

Carboplatin 346Cisplatin 240Paclitaxel 208Radiotherapy 207Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 147Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 102Etoposide 99Bevacizumab 96Specimen Handling 84Nivolumab 77Radiosurgery 74durvalumab 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 45Biopsy 43Radiation 42Irinotecan 42Topotecan 39Standard of Care 39Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Ketorolac × Clear all
NCT01932918 2015-07-23

Antinociceptive Modalities on Ischemia Reperfusion Injury

National Taiwan University Hospital

Completed
142 enrolled
Thoracic

Lung Neoplasms, Reperfusion Injury, End Stage Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡